Singapore attracts Lonza cell therapy investment
18 May 2009
Ian Haydock
Lonza is to invest around CHF30 million ($27.3 million) in a new facility in Singapore for the contract production of cell-based therapeutics. The plant is scheduled to become operational by mid-2011.
Construction will begin early next year on a site in the Tuas Biomedical Park, adjacent to the...
Please Login to read the full article.
18 May 2009
Ian Haydock
Construction will begin early next year on a site in the Tuas Biomedical Park, adjacent to the...
Please Login to read the full article.
RELATED CONTENT
NEWS
- MSD lays out $800mn investment programme for Singapore operations
- Asia Beat: Choppy waters on the horizon for Yellow Sea biocluster initiative
- Less investment but more value for Singapore biomedical sector last year
- Singapore earmarks major new funding for biomedical partnerships and research
COMMENT
Other Informa Comment
EVENTS
Today
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
